A porphyrin increases survival time of mice after intracerebral prion infection

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 2, 2006, Pages 759-761

  Kocisko, David A ^a,c   Caughey, Winslow S ^a   Race, Richard E ^a   Roper, Grant ^b   Caughey, Byron ^a   Morrey, John D ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UTAH STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER TETRAKIS(4 N,N,N TRIMETHYLANILINIUM)PORPHINE; COPPER TETRAKIS(4 SULFONATOPHENYL)PORPHINE; INDIUM TETRAKIS(4 SULFONATOPHENYL)PORPHINE; IRON TETRAKIS(4 N,N,N TRIMETHYLANILINIUM)PORPHINE; IRON TETRAKIS(4 SULFONATOPHENYL)PORPHINE; NICKEL TETRAKIS(4 N,N,N TRIMETHYLANILINIUM)PORPHINE; PALLADIUM TETRAKIS(4 N,N,N, TRIMETHYLANILINIUM)PORPHINE; PORPHYRIN DERIVATIVE; TETRAKIS(4 N,N,N TRIMETHYLANILINIUM)PORPHINE; TETRAKIS(4 SULFOPHENYL)PORPHINE; UNCLASSIFIED DRUG; ZINC TETRAKIS(4 N,N,N TRIMETHYLANILINIUM)PORPHINE; ZINC TETRAKIS(4 SULFONATOPHENYL)PORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG TOLERABILITY; INOCULATION; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE; SURVIVAL TIME; TREATMENT OUTCOME;

ANIMALS; BLOOD-BRAIN BARRIER; MICE; MICE, TRANSGENIC; PORPHYRINS; PRION DISEASES;

EID: 31944440581     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.2.759-761.2006     Document Type: Article

References (12)

1. Cashman, N. R., and B. Caughey. 2004. Prion diseases-close to effective therapy? Nat. Rev. Drug Discov. 3:874-884.
2. Caughey, W. S., L. D. Raymond, M. Horiuchi, and B. Caughey. 1998. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc. Natl. Acad. Sci. USA 95:12117-12122.
3. Doh-ura, K., K. Ishikawa, I. Murakami-Kubo, K. Sasaki, S. Mohri, R. Race, and T. Iwaki. 2004. Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J. Virol. 78:4999-5006.
4. Dormont, D. 2003. Approaches to prophylaxis and therapy. Br. Med. Bull. 66:281-292.
5. Forloni, G., S. Iussich, T. Awan, L. Colombo, N. Angeretti, L. Girola, I. Bertani, G. Poll, M. Caramelli, B. M. Grazia, L. Farina, L. Limido, G. Rossi, G. Giaccone, J. W. Ironside, O. Bugiani, M. Salmona, and F. Tagliavini. 2002. Tetracyclines affect prion infectivity. Proc. Natl. Acad. Sci. USA 99:10849-10854.
6. Ingrosso, L., A. Ladogana, and M. Pocchiari. 1995. Congo red prolongs the incubation period in scrapie-infected hamsters. J. Virol. 69:506-508.
7. Pocchiari, M., S. Schmittinger, and C. Masullo. 1987. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J. Gen. Virol. 68:219-223.
8. Priola, S. A., A. Raines, and W. Caughey. 2003. Prophylactic and therapeutic effects of phthalocyanine tetrasulfonate in scrapie-infected mice. J. Infect. Dis. 188:699-705.
9. Priola, S. A., A. Raines, and W. S. Caughey. 2000. Porphyrin and phthalocyanine antiscrapie compounds. Science 287:1503-1506.
10. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383.
11. Race, R., M. Oldstone, and B. Chesebro. 2000. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. J. Virol. 74:828-833.
12. Todd, N. V., J. Morrow, K. Doh-ura, S. Dealler, S. O'Hare, P. Farling, M. Duddy, and N. G. Rainov. 2005. Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease. J. Infect. 50:394-396.